Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
The role of inflammation in cardiovascular disease
MY Henein, S Vancheri, G Longo… - International journal of …, 2022 - mdpi.com
Atherosclerosis is a chronic inflammatory disease, in which the immune system has a
prominent role in its development and progression. Inflammation-induced endothelial …
prominent role in its development and progression. Inflammation-induced endothelial …
[HTML][HTML] Inflammation and cardiovascular disease: From mechanisms to therapeutics
Inflammation constitutes a complex, highly conserved cascade of molecular and cellular
events. Inflammation has been labeled as “the fire within,” is highly regulated, and is critical …
events. Inflammation has been labeled as “the fire within,” is highly regulated, and is critical …
Targeting the CCL2–CCR2 axis for atheroprotection
Decades of research have established atherosclerosis as an inflammatory disease. Only
recently though, clinical trials provided proof-of-concept evidence for the efficacy of anti …
recently though, clinical trials provided proof-of-concept evidence for the efficacy of anti …
Atherogenic index of plasma and coronary artery disease in the adult population: a meta-analysis
J Wu, Q Zhou, Z Wei, J Wei, M Cui - Frontiers in Cardiovascular …, 2021 - frontiersin.org
Background: The atherogenic index of plasma (AIP), which is the logarithm of the ratio
between the triglyceride and high-density lipoprotein cholesterol (TG/HDL-C) concentrations …
between the triglyceride and high-density lipoprotein cholesterol (TG/HDL-C) concentrations …
Monomeric C-reactive protein in atherosclerotic cardiovascular disease: advances and perspectives
I Melnikov, S Kozlov, O Saburova, Y Avtaeva… - International journal of …, 2023 - mdpi.com
This review aimed to trace the inflammatory pathway from the NLRP3 inflammasome to
monomeric C-reactive protein (mCRP) in atherosclerotic cardiovascular disease. CRP is the …
monomeric C-reactive protein (mCRP) in atherosclerotic cardiovascular disease. CRP is the …
Non-HDL cholesterol and residual risk of cardiovascular events in patients with ischemic heart disease and well-controlled LDL cholesterol: a cohort study
Background Identifying patients at high residual risk of atherosclerotic cardiovascular
disease (ASCVD) despite statin-treatment is of paramount clinical importance. We aim to …
disease (ASCVD) despite statin-treatment is of paramount clinical importance. We aim to …
[HTML][HTML] Clinical approach to the inflammatory etiology of cardiovascular diseases
Inflammation is an obligatory marker of arterial disease, both stemming from the
inflammatory activity of cholesterol itself and from well-established molecular mechanisms …
inflammatory activity of cholesterol itself and from well-established molecular mechanisms …
Synergistic effect of the commonest residual risk factors, remnant cholesterol, lipoprotein (a), and inflammation, on prognosis of statin-treated patients with chronic …
HH Liu, YL Guo, CG Zhu, NQ Wu, Y Gao, RX Xu… - Journal of Translational …, 2022 - Springer
Background Currently, remnant cholesterol (RC), lipoprotein (a)[Lp (a)], and inflammation
are considered the principal residual cardiovascular risk (RCVR) factors. This study sought …
are considered the principal residual cardiovascular risk (RCVR) factors. This study sought …
Inflammation during percutaneous coronary intervention—prognostic value, mechanisms and therapeutic targets
Periprocedural myocardial injury and myocardial infarction (MI) are not infrequent
complications of percutaneous coronary intervention (PCI) and are associated with greater …
complications of percutaneous coronary intervention (PCI) and are associated with greater …
Systemic inflammation and health outcomes in patients receiving treatment for atherosclerotic cardiovascular disease
Abstract Background and Aims The burden and outcomes of inflammation in patients with
atherosclerotic cardiovascular disease (ASCVD) are not well defined beyond the controlled …
atherosclerotic cardiovascular disease (ASCVD) are not well defined beyond the controlled …